News from nanomosaic A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 24, 2023, 06:30 ET NanoMosaic To Develop Novel Capture Methodologies as Dr. Abhishek Chatterjee Joins NanoMosaic Scientific Advisory Board

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, announced the establishment of Scientific...

Dec 13, 2022, 11:55 ET NanoMosaic Wins the Prestigious NEVY Award (New England Venture Capital) for Emerging MedTech Company of the Year

NanoMosaic, the leader in next-generation digital proteomic interrogation technology, won the prestigious NEVY, New England Venture Capital award,...

Nov 09, 2022, 08:57 ET Dr. George Green Joins NanoMosaic Scientific Advisory Board

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, announced the establishment of the...

Oct 20, 2022, 08:37 ET NanoMosaic: John Boyce To Continue to Build Tiger Gene, Remain as Executive Chairman of the Board, and Hire a Full-Time CEO

John Boyce, who founded Tiger Gene with Julian Robertson of Tiger Management, and subsequently founded, funded (through Tiger Gene), and built...

Oct 12, 2022, 09:45 ET NanoMosaic Expands Its Diagnostic Repertoire with Exclusive Rights to Novel Clinical Biomarker Test

NanoMosaic, a leader in proteomics and multi-omics via its novel MosaicNeedle™ technology and Tessie™ system has expanded its diagnostic capabilities ...

Sep 20, 2022, 10:44 ET Publication on NanoMosaic Technology in the, "British Journal of Anaesthesia"

With NanoMosaic's nanoneedle technology, researchers from Massachusetts General Hospital and Harvard Medical School detected Tau and phosphor-Tau...

Jul 25, 2022, 08:01 ET NANOMOSAIC APPOINTS RAAJ VENKATESAN AS CHIEF REGULATORY OFFICER

Following the pivotal announcement of the publication, for the use of the Nanomosaic Tessie™ platform to elucidate the biomarker association between...

Jul 11, 2022, 11:13 ET Groundbreaking Clinical Diagnostics: NanoMosaic Tessie™ Platform Elucidates Critical Diagnostic Biomarker Association Between PTau217 and PTau181 and Post-Operative Delirium in Patient Plasma

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, has demonstrated the detection of...

Jun 03, 2022, 10:53 ET NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in...

Apr 04, 2022, 08:47 ET NanoMosaic Unveils a Method To Enable Proteomics By Combining Aptamers and Antibodies on its MosaicNeedle™ Platform at 2022 AACR

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, was invited to present a poster at the...

Feb 15, 2022, 08:19 ET NanoMosaic Announces Its Second Commercial Sale of the World's First Proteomics/Multi-Omics System, Tessie™, for Clinical Diagnostic Test Development, Under Its Early Access Program

NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment...

Feb 02, 2022, 07:03 ET NanoMosaic Announces its "Proteomics/Multi-Omics Early Access Program" and its First System Sale to a Prestigious Boston Hospital

NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment...

Jan 24, 2022, 07:03 ET NanoMosaic Signs 31K Square Foot Lease and Establishes "Multi-Omics World Headquarters" in Waltham, MA

NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics ...

Dec 06, 2021, 07:03 ET NanoMosaic Closes a $40.75MM Over-Subscribed Series A Round

NanoMosaic Inc., a Tiger Gene founded company that has established itself as the pioneer and leader in nanoneedle (MosaicNeedle™) detection for...

Oct 20, 2021, 07:04 ET NanoMosaic Demonstrates Robust Aptamer Performance for Protein Quantitation on the Company's Tessie™ System

NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics applications has demonstrated unoptimized,...

Apr 13, 2021, 07:47 ET NanoMosaic Unveils Full Proteome Wide Association Study (PWAS) Marker Set Development at the 2021 Annual American Association of Cancer Research (AACR) Meeting

NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics, was invited to, and presented a talk, at the...

Apr 06, 2021, 07:07 ET NanoMosaic Installs Wide Dynamic Range Proteomic Beta System at The New York Stem Cell Foundation Research Institute (NYSCF)

NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics, has installed its end-user fully...

Dec 16, 2020, 07:07 ET NanoMosaic Announces Beta Placement of its Tessie™ System at Massachusetts General Hospital to Run Clinical Samples

NanoMosaic has developed a streamlined platform with novel physical structures, MosaicNeedles™, to enable enhanced-generation digital protein...

Oct 28, 2020, 07:00 ET NanoMosaic Ships First Beta System To A Prestigious Institution

NanoMosaic, the pioneer in protein interrogation via proprietary nanoneedles, "MosaicNeedles™," has announced that on October 15, 2020 it shipped its ...

Oct 14, 2020, 07:00 ET Protein Detection Pioneer, NanoMosaic, Prepares to Ship Its Powerful New Beta Platform in the Battle Against Cancer and Complex Diseases

NanoMosaic a leading proteomics company, leveraging the power of MosaicNeedles has developed a complete benchtop system, Tessie, to push the frontier ...

Jul 01, 2020, 07:00 ET 2020 American Association of Cancer Research: NanoMosaic Unveils Ultra-sensitive, Quantitative Platform to Further Immunotherapy and to Enable Whole Proteome Biomarker Discovery

WOBURN, Mass., July 1, 2020 NanoMosaic L.L.C. – Woburn, MA – the leading company in protein and nucleic acid detection leveraging the power of...

Apr 06, 2020, 07:30 ET NanoMosaic announces collaboration with Massachusetts General Hospital to Develop Test for COVID-19

NanoMosaic L.L.C. – the leading company in protein and nucleic acid detection leveraging the power of nanoneedles for ultra-sensitive, wide dynamic...

Apr 02, 2020, 08:00 ET NanoMosaic Announces Exclusive License to Nanoneedle Technology from Harvard

NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at...